Intravenous pamidronate attenuates bone density loss after acute spinal cord injury

Archives of Physical Medicine and Rehabilitation

Volumn 80, Issue 3, 1999, Pages 243-251

  Nance, Patricia W ^a,b,e,g   Schryvers, Orpha ^a,b,e,g   Leslie, William ^c,e,f,g   Ludwig, Sora ^d,e,f,g   Krahn, John ^e,f,g   Uebelhart, Daniel ^h,i  

^a HEALTH SCIENCES CENTRE   (Canada)

^b Sect of Phys Med and Rehab   (Canada)

^c Section of Nuclear Medicine   (Canada)

^d Section of Endocrinology   (Canada)

^e Department of Biochemistry ^*  (Canada)

^f ST BONIFACE GENERAL HOSPITAL   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

^h UNIVERSITY HOSPITAL   (Switzerland)

ⁱ RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; PAMIDRONIC ACID; PROCOLLAGEN;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEG; MALE; OSTEOPOROSIS; SPINAL CORD INJURY; SPINE; URINARY EXCRETION;

EID: 0032978038     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(99)90133-8     Document Type: Article

References (83)

1. Albright F, Burnett CH, Gope O, Parsons W. Acute atrophy of bone (osteoporosis) simulating hyperparathyroidism. J Clin Endocrinol 1941;1:711.
2. Wyse DM, Pattee CJ. Effect of oscillating bed and tilt table on calcium, phosphorus and nitrogen metabolism in paraplegia. Am J Med 1954;645-61.
3. Klein L, Curtis PH. Urinary hydroxyproline as an index of bone metabolism. In: Pearson OH, Joplin GF, editors. Dynamic studies of metabolic bone diseases. Oxford: Blackwell Scientific Publications; 1964. p. 201-44.
4. Minaire P, Meunier P, Edouard C, Bernard J, Courpron P, Bourret J. Quantitative histological data on disuse osteoporosis. Comparison with biological data. Calcif Tissue Int 1974;17:57-73.
5. Claus-Walker J, Spencer WA, Carter RE, Halstead LS, Meier III RH, Campos RJ. Bone metabolism in quadriplegia: dissociation between calciuria and hydroxyprolinuria. Arch Phys Med Rehabil 1975;56:327-32.
6. Kaplan PE, Gandhavadi B, Richards L, Goldschmidt J. Calcium balance in paraplegic patients: influence of injury duration and ambulation. Arch Phys Med Rehabil 1978;59:447-50.
7. Chantraine A. Actual concept of osteoporosis in paraplegia. Paraplegia 1978-1979;16:51-8.
8. Naftchi NE, Viau AT, Sell GH, Lowman EW. Spinal cord injury: effect of thyrocalcitonin on calcium, magnesium and phosphorus in paraplegic rats. Arch Phys Med Rehabil 1980;61:575-9.
9. Stewart AF, Adler M, Byers CM, Serge GV, Broadus AE. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med 1982;306:1136-40.
10. Maynard FM. Immobilization hypercalcemia following spinal cord injury. Arch Phys Med Rehabil 1986;67:41-4.
11. Chantraine A. Bone remodeling during the development of osteoporosis in paraplegia. Calcif Tissue Int 1986;38:323-7.
12. Claus-Walker J, Scurry RE, Carter RE, Campos RJ. Steady-state hormonal secretion in traumatic quadriplegia. J Clin Endocrinol Metab 1977;44:530.
13. Gallacher SJ, Ralston SH, Dryburgh FJ, Logue FC, Allam BF, Boyce BF, et al. Immobilization-related hypercalcaemia - a possible novel mechanism and response to pamidronate. Postgrad Med J 1990;66:918-22.
14. Griffiths HJ, Bushueff B, Zimmerman RE. Investigation of the loss of bone mineral in patients with spinal cord injury. Paraplegia 1976;14:207-12.
15. Kiratli BJ, Agre JC. Disuse osteoporosis in spinal cord injured patients. Rehabil Res Dev Progr Rep 1990;425-6.
16. Biering-Sørensen F, Bohr HH, Schaadt OP. Bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury. Paraplegia 1988;26:293-301.
17. Leeds EM, Klose KJ, Ganz W, Serafini A, Green BA. Bone mineral density after bicycle ergometry training. Arch Phys Med Rehabil 1990;71:207-9.
18. Garland DE, Stewart CA, Adkins RH, Hu SS, Rosen C, Liotta FJ, et al. Osteoporosis after spinal cord injury. J Orthop Res 1992;10: 371-8.
19. Leslie WD, Nance PW. Dissociated hip and spine demineralization: a specific finding in spinal cord injury. Arch Phys Med Rehabil 1993;74:960-4.
20. Chow YW, Inman C, Pollintine P, Sharp CA, Haddaway MJ, Masry WE, et al. Ultrasound bone densitometry and dual energy X-ray absorptiometry in patients with spinal cord injury. Spinal Cord 1996;34:736-41.
21. Wolff JD. Geretz de transformation der knochen. Berlin: Hirchwald; 1892.
22. Martin RB. Determinants of the mechanical properties of bones. J Biomech 1991;24(S1):79-88.
23. Lanyon LE. The success and failure of the adaptive response to functional load-bearing in averting bone fracture. Bone 1992;13: S17-22.
24. Goodship AE. Mechanical stimulus to bone. Ann Rheum Dis 1992:51:4-6.
25. Yasuda I. Fundamental aspect of fracture treatment. J Kyoto Med Soc 1953;4:395-406.
26. Brighton CT, Friedenberg ZB, Mitchell EL, Booth RE. Treatment of nonunion with constant direct current. Clin Orthop 1977;124: 106-23.
27. Inoue S, Ohashi T, Kajikawa K, Ibaraki K, Sasaki H, Tada M. Application of electric stimulation methods for bone fracture and disease. Clin Orthop Surg 1983;18:1291-8.
28. Kunkel CF, Scremin AME, Eisenberg B, Garcia JF, Roberts S, Martinez S. Effect of "standing" on spasticity, contracture, and osteoporosis in paralyzed males. Arch Phys Med Rehabil 1993;74: 73-8.
29. Pearson E, Nance PW, Leslie WD, Ludwig S. Cyclical etidronate: its effect on bone density in patients with acute spinal cord injury. Arch Phys Med Rehabil 1997;78:269-72.
30. Avioli LV. Calcitonin therapy in osteoporotic syndromes. J Am Med Womens Assoc 1990;45:103-7.
31. Stevenson JC. Pathogenesis, prevention and treatment of osteoporosis. Obstet Gynecol 1990;75:36S-41S.
32. Licata AA. Therapies for symptomatic primary osteoporosis. Geriatrics 1991;46:62-7.
33. Minaire P. Immobilization osteoporosis: a review. Clin Rheumatol 1989;8 Suppl 2:95-103.
34. Pearson E, Nance PW, Leslie WD, Ludwig S. Severe adverse effects following the use of calcitonin to prevent osteoporosis in acute spinal cord injury (SCI) [abstract]. Clin Invest Med 1993;16 Suppl 4:B112.
35. Stone MD, Hosking DJ. Treatment of osteoporosis: current and future. Ann Rheum Dis 1991;50:663-5.
36. Consensus development conference: prophylaxis and treatment of osteoporosis [conference report]. Am J Med 1991;90:107-10.
37. Reeve J, Davies UM, Hesp R, McNally E, Katz D. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride. BMJ 1990;301:314-8.
38. Kanis JA, McCloskey EV, Taube T, O'Rourke N. Rationale for the use of bisphosphonates in bone metastases. Bone 1991;12 Suppl 1:S13-8.
39. Powell JH, Denmark BR. Clinical pharmacokinetics of diphosphonates. In: Garrafini S, editor. Bone resorption metastasis and diphosphonates. New York: Raven Press; 1985. p. 41-9.
40. Russell RGG, Fleisch H. Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects. Clin Orthop 1975;108:241-63.
41. Shinoda H, Ademek G, Felix R, Fleisch H, Schenk P, Hagan P. Structure-activity relationships of various bisphosphenates. Calcif Tissue Int 1983;35:87-99.
42. Elomaa I, Blomqvist C, Porkka L, Lamberg-Allardt C, Borgstrom GH. Treatment of skeletal disease in breast cancer: a controlled clodronate trial. Bone 1987;8 Suppl 1:53-6.
43. Mallette LE, Leblanc AD, Pool JL, Mechanick JI. Cyclic therapy of osteoporosis with neutral phosphonate and brief, high-dose pulses of etidronate. J Bone Miner Res 1989;4:143-8.
44. Minaire P, Depassio J, Berard E, Meunier PJ, Edouard C, Pilonchery G, et al. Effects of clodronate on immobilization bone loss. Bone 1987;8 Suppl 1:S63-8.
45. Gucalp R, Ritch P, Wiernik PH, Sarma PR, Keller A, Richman SP, et al. Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia. J Clin Oncol 1992;10:134-42.
46. Boonekamp PM, van der Wee-Pals LJA, van Wijk-van Lennep MML, Thesing CW, Bijvoet OLM. Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. Bone Miner 1986;1:27-39.
47. Ralston SH, Gallacher SJ, Patel U, Dryburgh FJ, Fraser WD, Cowan RA, et al. Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia. Lancet 1989;2:1180-2.
48. Carey PO, Lippert MC. Treatment of painful prostatic bone metastases with oral etidronate disodium. Urology 1988;32:403-7.
49. Pelger RCM, Lycklama A, Nijeholt AAB, Papapoulos SE. Short-term metabolic effects of pamidronate in patients with prostatic carcinoma and bone metastases. Lancet 1989;2:865.
50. Reid IR, Alexander CJ, King AR, Ibbertson HK. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (APD). Lancet 1988;1:143-6.
51. Reid IR, Schooler BA, Stewart AW. Prevention of glucocorticoid-induced osteoporosis. J Bone Miner Res 1990;5:619-23.
52. Gallacher SJ, Fenner JAK, Anderson K, Bryden FM, Banham SW, Logue FC, et al. Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study. Thorax 1992;47:932-6.
53. Hanson DA, Weis MAE, Bollen AM, Maslan SH, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: Quantification of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251-8.
54. Ebeling PR, Atley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper JL, et al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 1996;81:3366-71.
55. Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clemens JD, et al. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as markers of bone turnover in humans. Calcif Tissue Int 1994;54:26-9.
56. Gertz BJ, Shao P, Hanson DA, Quan H, Harris ST, Genant HK, et al. Monitoring bone resorption in early post menopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res 1994;9:135-42.
57. Roberts D, Lee W, Cuneo RC, Wittmann J, Ward G, Flatman R, et al. Longitudinal study of bone turnover after acute spinal cord injury. J Clin Endocrinol Metab 1998;83:415-22.
58. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Assessment of 8 markers of bone turnover in post menopausal (PMP) osteoporotic women treated with alendronate (ALN) [abstract]. Second Workshop on Bisphosphonates; 1994; Davos, Switzerland.
59. Johnston CC, Slemenda CW, Melton LJ. Clinical use of bone densitometry. N Engl J Med 1991;324:1105-9.
60. Winer BJ. Statistical principles in experimental design. 2nd ed. New York: McGraw-Hill; 1971.
61. Biering-Sørensen F, Bohr HH, Schaadt OP. Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury. Eur J Clin Invest 1990;20:330-35.
62. Rodgers MM, Glaser RM, Figoni SF, Hooker SP, Ezenwa BN, Collins SR, et al. Musculoskeletal responses of spinal cord injured individuals to functional neuromuscular stimulation-induced knee extension exercise training. J Rehabil Res Dev 1991;28:19-26.
63. Henderson RC. Bone density and other possible predictors of fracture risk in children and adolescents with spastic quadriplegia. Dev Med Child Neurol 1997;39:224-7.
64. Moynaham M, Betz RR, Triolo RJ, Maurer AH. Characterization of the bone mineral density of children with spinal cord injury. J Spinal Cord Med 1996;19:249-54.
65. Szollar SM, Martin EME, Parthemore JG, Sartoris DJ, Deftos LJ. Demineralization in tetraplegic and paraplegic man over time. Spinal Cord 1997;35:223-8.
66. Szollar SM, Martin EME, Parthemore JG, Sartoris DJ, Deftos LJ. Densitometric patterns of spinal cord injury associated bone loss. Spinal Cord 1997;35:374-82.
67. Comarr AE, Hutchinson RH, Bors E. Extremity fractures of patients with spinal cord injuries. Am J Surg 1962;103:732-9.
68. Ragnarsson KT, Sell G. Lower extremity fractures after spinal cord injury: a retrospective study. Arch Phys Med Rehabil 1981;62: 418-23.
69. Ingram RR, Suman RK, Freeman PA. Lower limb fractures in the chronic spinal cord injured patient. Paraplegia 1989;27:133-9.
70. Wilmet E, Ismail AA, Heilporn A, Welraeds D, Bergmann P. Longitudinal study of the bone mineral content and of soft tissue composition after spinal cord section. Paraplegia 1995;33:674-7.
71. Uebelhart D, Derniaux-Domenech B, Roth M, Chantraine A. Bone metabolism in spinal cord injured individuals and in others who have prolonged immobilisation: a review. Paraplegia 1995;33: 669-73.
72. Sloan KE, Bremner LA, Byrne J, Day RE, Scull ER. Musculoskeletal effects of an electrical stimulation induced cycling program in the spinal injured. Paraplegia 1994;32:407-15.
73. Hangartner TN, Rodgers MM, Glaser RM, Barre PS. Tibial bone density loss in spinal cord injured patients: effects of FES exercise. J Rehabil Res 1994;31:50-61.
74. BeDell KK, Scremin AME, Perell KL, Kunkel CF. Effects of functional electrical stimulation-induced lower extremity cycling on bone density of spinal cord injured patients. Am J Phys Med Rehabil 1996;75:29-34.
75. Needham-Shropshire BM, Broton JG, Klose J, Lebwohl N, Guest RS, Jacobs PL. Evaluation of a training program for persons with SCI paraplegia using the Parastep® 1 ambulation system: part 3. Lack of effect on bone mineral density. Arch Phys Med Rehabil 1997;78:799-803.
76. Bloomfield SA, Mysiw WJ, Jackson RD. Bone mass and endocrine adaptations to training in spinal cord injured individuals. Bone 1996;19:61-8.
77. Mohr T, Pødenphant J, Biering-Sørensen F, Galbo H, Thamsborg G, Kjaer M. Increased bone mineral density after prolonged electrically induced cycle training of paralyzed limbs in spinal cord injured man. Calcif Tissue Int 1997;61:22-5.
78. Changlai SP, Kao CH. Bone mineral density in patients with spinal cord injuries. Nucl Med Commun 1996;17:385-8.
79. Saltzstein RJ, Hardin S, Hastings J. Osteoporosis in spinal cord injury: using an index of mobility and its relationship to bone density. J Am Paraplegia Soc 1992;15:232-4.
80. Chappard D, Minaire P, Privat C, Berard E, Mendoza-Sarmiento J, Tournebise H, et al. Effects of tiludronate on bone loss in paraplegic patients. J Bone Miner Res 1995;10:112-8.
81. Orr-Walker B, Wattie DJ, Evans MC, Reid IR. Effects of prolonged bisphosphonate therapy and its discontinuation on bone mineral density in post-menopausal osteoporosis. Clin Endocrinol 1997;46: 87-92.
82. Chapurlat RD, Duboeuf FP, Liens D, Meunier PJ. Dual energy x-ray absortiometry in patients with lower limb reflex sympathetic dystrophy syndrome. J Rheumatol 1996;23:1557-9.
83. Roux C, Ravaud P, Cohen-Solal M, de Vernejoul MC, Guíllemant S, Cherruau B, et al. Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma. Bone 1994;15:41-9.